Option One- HYBRID - Part in person, Part on-line. 

A hybrid training where the first 4 hours are in person, and the remaining are online: 4 hours for MDs/DOs; and 20 hours online for NPs, PAs, CNMs

*Our "in-person" trainings will now be live virtual trainings. Please see below for upcoming dates-

We currently do not have any trainings scheduled. Please check back for new dates. 

For CME Information Click Here

The American Academy of Addiction Psychiatry is the sponsoring data organization for these trainings. Funding for these courses were made possible (in part) by 1U79TI026556 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government CME Accreditation: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AAAP and University of Colorado Denver. AAAP is accredited by the ACCME to provide continuing medical education for physicians.

Option Two – Online Training Options

• MDs, DOs and Residents (8 Hours)
  • American Society of Addiction Medicine (ASAM)  –$200 for MD's and DO's and Free to residents that are members of ASAM- https://elearning.asam.org/products/treatment-of-opioid-use-disorder-waiver-qualifying-it-matttrs
  • The American Academy of Addiction Psychiatry (AAAP) Buprenorphine Waiver Training - $196 for non-members / $124 for members  - https://www.aaap.org/education-training/buprenorphine/
  • Providers' Clinical Support System for Medication Assisted Treatment (PCSS-MAT) - FREE Scheduled Live Training - http://pcssmat.org/education-training/mat-waiver-training/
• PAs and NPs (24 Hours)
  • The 24 hours of training is offered by
    • PCSS-MAT – FREE - http://pcssmat.org/education-training/mat-waiver-training/
    • ASAM Ob-Gyn Focus – FREE https://elearning.asam.org/products/nppa-24-hour-waiver-training-aapa

• Upon completion of the MAT waiver training, providers must apply for a waiver through the Drug Enforcement Agency (DEA) to prescribe buprenorphine.  You will need the following information:
  • All will need a Certificate of Completion for the 8 hour MAT training.
  • NPs, PAs, CNSs, CNMs, and CRNAs will need a Certificate of Completion for the additional 16-hour training required.
• The waiver applications are forwarded to the DEA, which assigns the prescriber a special identification number.  The DEA regulations require that this number, and the provider's regular DEA registration number, be included on all buprenorphine prescriptions.
• The application process takes about 45 days.  If the application is approved, the provider will receive a letter that confirms their waiver and contains the new buprenorphine prescribing identification number. Prescribers are capped at 30 MAT patients for the first year. After the first year of being limited to 30 patients you can apply online to increase to 100 patients, and a year after that you can apply again to increase to up to 275 patients at any one time. 
• Residents won’t actually complete their Notice of Intent (NOI) form until they have their unrestricted DEA license.  At the conclusion of the training, they will get a survey which will generate their certificate.  They should hold on to this certificate and then when it’s time to apply for their waiver they can submit it with their NOI form. Residents may apply for the remaining $240 Waiver incentive within 3 months of completing their training.

MAT Communications

A guide to DEA-X waiver practices who want to increase awareness in their communities about MAT services.

MAT Rack Card English

MAT Rack Card Spanish

MAT Flyer English

MAT Flyer Spanish